Orexigen Therapeutics Inc (NASDAQ:OREX)

4.76
Delayed Data
As of Jul 02
 -0.17 / -3.45%
Today’s Change
3.11
Today|||52-Week Range
9.37
-21.45%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 10.50, with a high estimate of 17.00 and a low estimate of 8.00. The median estimate represents a +120.59% increase from the last price of 4.76.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.16
Sales
$4.9M
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -16.59%
 
 
 
 
 
 
Growthannually -109.06%
 
 
 
 
 
 

Sales

Growthquarterly 13.01%
 
 
 
 
 
 
Growthannually -44.07%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account